徳島大学21世紀COEプログラム「ストレス制御をめざす栄養科学」
Home
Reserch Aim
COE Members
Projects
Research Plans
Papers
Coming Events
Call for Students
Equipments
Contact us
2007 International Conference
Papers
ストレス制御をめざす栄養科学

Mari Tabuchi, et al.: Self-Contained On-Chip Cell Culture and Pretreatment System. Journal of Proteome Research, vol.3 Issue4, 2004

Hidekazu Arai, et al.: Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion.  Metabolism,  in press
 
Tomoko Koda, et al.: Higher Concentrations of Interferon-γ Enhances Uptake and Transport of Dietary Antigens by Human Intestinal Cells : A Study Using Cultured Caco-2 Cells. J. Nutr. Sci. Vitaminol., 49, 179-186, 2003
 
Naoya Ikeda, et al.: Combination treatment with 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells.  Mol. Cancer Ther., 8, 739-746, 2003
 
Yutaka Taketani, et al.:  Increase in IP3 and intracellular Ca2+ induced by phosphate depletion in LLC-PK1 cell. Biochem. Biophys. Res. Commun., 305, 287-291, 2003
 
Hironori Yamamoto, et al.: 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J. Biol. Chem., 278(34): 31756-31765, 2003
 
Wesley J. Pike, et al.: Synthetic LXXLL peptides antagonize 1,25-dihydroxyvitamin D3-dependent transcription. J. Cell. Biochem., 88, 252-258, 2003
 
Eiji Takeda, et al.: The understanding in inorganic phosphate homeostasis and the role of dietary phosphorus.  J. Cell. Mol. Med., in press
 
Kato Y, et al.:  Inhibition of myeloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro. Biosci Biotechnol Biochem., 67, 1136-1139, 2003
 
Natsume M, et al.:  Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radic. Biol. Med., 34, 840-849, 2003.
 
Murota K, et al.: Antioxidative flavonoid qyercetin:implicatrion of its intestinal absorption and metabolism  Arch. Biochem. Biophys.,  417, 12-17, 2003.
 
Miyamoto S., et al.: Phospholipid hydroperoxides are detoxified by phospholipase A2 and GSH peroxidase in rat gastric mucosa. Lipids, 38, 641-649, 2003
 
Baba S, et al..: Absorption,metabolism, degradation and urinary excretion of rosmatic acid after intake of perilla frutescens extract in humans.  Eur. J. Nutr., In press
 
Murota K., et al.: Quercetin-4’-glucoside in more potent than quercetin-3-glucoside in protection of rat intestinal mucosa homogenates aganst iron ion-induced lipid peroxidation  J. Agric. Food Chem., 52,1907-1912, 2004
 
Baba S., et al.: Orally administered rosmariinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid.  Life Sci., in press
 
M. Tabuchi, et al.: A 15-seconds Protein Separation by Employing Hydrodynamic Force on a Microchip. Anal. Chem., 75 (15), 3799-3805, 2003
 
M. Tabuchi, et al.: Rapid Subpicogram Protein Detection on a Microchip without Denaturing.  J. Proteome Res., 2 (4), 431-435, 2003
 
K. Kajimoto, et al.: PCR-Select Subtraction for Characterization of Messages Differentially Expressed in Brown Compared with White Adipose Tissue.  Molecular Genetics and Metabolism, 80, 255-261, 2003
 
A. Unami, et al.: Comparison of Gene Expression Profiles Between White and Brown Adipose Tissue of Rat by Microarray Analysis.  Biochemical Pharmacology, 76 (1), 555-564, 2004
 
Z. Zhelev, et al.: Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells, without any influence on the viability of normal lymphocytes.  Cancer Chemotherapy and Pharmacology, 53, 267-275, 2004
 
M. Tabuchi, et al.: Nanospheres for DNA Separation Chips.  Nature Biotech., 22(3), 337-340, 2004
 
R. Bakalova, et al.: Antisense inhibition of bcr-abl/c-abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.  FEBS Lett., in press
 
Hideji Tanaka, et al.: Determination of the Chloroform/Water distribution Coefficient of Weak Acids by a Stepwise Flow Ratiometry.  J. Flow Inject. Anal., 20, 43-48, 2003
 
Hideji Tanaka, et al.: Determination of dissociation constants of weak acids by feedback-based flow ratiometry.  Anal.Chim.Acta., 499, 199-204, 2003
 
Nodera H, et al.: Nerve excitability properties in Sharcot-Marie-Tooth disease type 1A. Brain, 127, 203-211, 2003
 
Matsumoto S, et al.: Epidemiology of primary dystonias in Japan: comparison with Western countries. Mov Disord, 18(10), 1196-1198, 2003
 

Kaji R, et al.: Sensory deficits in dystonia and their significance. Adv Neurol, 94, 11-17, 2004

 
Nishimura M, et al.: Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson’s disease.
 
Matsumoto S, et al.: Modulation of the onset age in primary dystonia by APOE genotype. Neurology. 60(12), 2003-2005, 2003
 

Kanemoto K, et al.: Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia. 44(6): 796-799. 2003

 
Asanuma K, et al.: Treatment of facial spasm using botulinum toxin. No Shinkei Geka., 31(5), 487-491, 2003
 

Mitani K, et al.: Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. Intern Med., 42(3), 277-280, 2003

 
Asanuma K, et al.: Premovement  gating of somatosensory evoked potentials after tibial nerve stimulation. Neuroreport 14(3), 357-359, 2003
 

Yoshida K, et al.: Movement related cortical potentials before jaw excursions in oromandibular dystonia. Mov Disord. 18(1), 94-100, 2003

 
Manabe S, et al.: Decreased blood levels of lactic acid and urinary excretion of 3-methylhistidine after exercise by chronic taurine treatment in rats. J Nutr Sci Vitaminol (Tokyo), 49(6), 375-380, 2003
 
Minami A, et al.: Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes. 52(11), 2657-2665, 2003
 
Kawano T, et al.:  Supplementation of L-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats. Life Sci., 73(23), 3017-3026, 2003
 
Kanezaki Y, et al.:  Injection of the insulin receptor alpha subunit increases blood glucose levels in mice. Biochem Biophys Res Commun., 309(3), 572-577, 2003
 
Okamoto H, et al.:  Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. Intern Med., 42(8), 655-664, 2003
 
Katoh K, et al.:  Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: evaluation by electrogastrography and analysis of heart rate variability. J Gastroenterol., 38(7):629-635, 2003
 
Nomura M, et al.:  Effects of benidipine hydrochloride on autonomic nervous activity in hypertensive patients with high- and low-salt diets. Arzneimittelforschung., 53(5), 314-320, 2003
 
Kinoshita M, et al.:  Myocardial perfusion magnetic resonance imaging for diagnosing coronary arterial stenosis. Jpn Heart J., 44(3), 323-334, 2003
 
Uehara K, et al.:  High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction. Heart Vessels., 18(2), 67-74, 2003
 
Iga A, et al.:  Autonomic nervous dysfunction in patients with liver cirrhosis using 123I-metaiodobenzylguanidine myocardial scintigraphy and spectrum analysis of heart-rate variability. J Gastroenterol Hepatol., 18(6), 651-659, 2003
 
Miki M, et al.:  Effect of human airway trypsin-like protease on intracellular free Ca2+ concentration in human bronchial epithelial cells. J Med Invest., 50(1-2), 95-107, 2003
 
Shinkawa K, et al.: Effects of erythromycin and clarithromycin on chloride channels in bronchial epithelial cells. Jpn J Antibiot., 54 Suppl C:59-62, 2001
 
Harada K, et al.: Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. Circ J., 67(2), 139-145, 2003
 
Kusunoki M, et al.: Ethyl icosapentate (omega-3 fatty acid) causes accumulation of lipids in skeletal muscle but suppresses insulin resistance in OLETF rats. Otsuka Long-Evans Tokushima Fatty. Metabolism., 52(1), 30-34, 2003
 
Kusunoki M, et al.:  Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats. Metabolism., 53(2), 260-263, 2004
 
Kawano T, et al.:  Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology., 100(2), 338-346, 2004
 
Takishita E, et al.: Effect of sarpogrelate hydrochloride, a 5-HT2 blocker, on insulin resistance in Otsuka Long-Evans Tokushima fatty rats (OLETF rats), a type 2 diabetic rat model. J Cardiovasc Pharmacol. 2004, 43(2):266-270, 2004
 
Kakui S, et al.:   Localization of the 31-amino-acid endothelin-1 in hamster tissue.  Life Sci., 74(11), 1435-1443, 2004
 
Kusunoki K, et al.: Detection of coronary arterial microvascular disorders using  (99m)Tc-tetrofosmin uptake increase during exercise and coronary blood flow  velocity patterns obtained by magnetic resonance imaging.  Heart Vessels. 19(1), 1-7, 2004
 
Minami A, et al.: Increased insulin sensitivity and hypoinsulinemia in APS knockout mice.  Diabetes., 52(11), 2657-2665, 2003
 
Segawa H, et al.: Growth-related renal type II Na/Pi cotransporter. J Biol Chem, 277, 19665-19672, 2002
 
Saito H, et al.: Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1α, 25-dihydroxyvitamin D3 production. JBiol Chem, 278, 2206-2211, 2003.
 

Segawa H, et al.: Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter. Pflugers Arch-Eur J Physiol, 446, 585-592, 2003.

 

Ohkido I, et al.: Cloning gene structure and dietary regulation of the type-IIc Na/Pi cotransporter in the mouse kidney. Pflugers Arch, 446, 106-115, 2003.

 

Chamulitrat W, et al.: A Constitutive NADPH Oxidase-like System containing the gp91phox Homolog Nox1 in Human Keratinocytes. J. Invest. Dermatol., 2004 (in press)

 

Kawahara T, et al.: Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to toll-like receptor 5 signaling in large intestinal epithelial cells. J. Immunol., 172, 3051-3058, 2004

 

Yoneda K, et al.: Stimulation of human bronchial epithelial cells by IgE-dependent histamine-releasing factor. Am. J. Physiol. Lung Cell. Mol. Physiol., 286, L174-L181, 2004

 

Miyake H, et al.: Heat shock protein 70 induction in hepatocytes after right portal vein embolization. Hepatogastroenterology, 50, 2084-2087, 2003

 

Chamulitrat W, et al.: Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene, 22, 6045-6053, 2003

 

Masahuto Tomotake, et al.: TEMPERAMENT, CHARACTER AND EATING ATTITUDES IN JAPANESE COLLEGE WOMEN.  Psychological Reports  92: 1162-1168, 2003

 

Yasuhiro Kaneda, et al.: REPETITIVE BEHAVIORS IN CHRONIC SCHIZOPHRENIAUSING THE JAPANESE VERSION OF THE ELGIN BEHAVIOR RATING SCALE(JEBRS).  Intern J Neuroscience  113: 879-890, 2003

 

Yasuhiro Kaneda, et al.: Impact of risperidone medication on quality of life and gonadal axis hormones In schizophrenia male patients with acute exacerbation.  International Journal of Neuropsychopharmacology  6: 247-252, 2003

 

Yasuhiro Kaneda, et al.: Effects of quetiapine on gonadal axis hormones in male patients with schizophrenia:a preliminary, open study.  Progress in Neuro-Psychopharmacology & Biological Psychiatry  27: 875-878, 2003

 

Yasuhiro Kaneda, et al.: STATE-ANXIETY IN SCHIZOPHRENIA. Eur J Psychiat 17(2): 99-105, 2003

 

Ken Yamauchi, et al.: CASE OF SOCIAL PHOBIA WITH OBSESSIVE COMPULSIVE SYMPTOM IMPROVED BY PAROXETINE IN COMBINATION WITH RISPERIDONE. General Hospital Psychiatryin press

 

Kaneda Y: Depressive symptoms in chronic schizophrenia patients: any differences between patients with and without a major depressive episode?  European Psychiatry18137-1392003

 
Kaneda Y, et al.: Quetiapine Impact on Quality of Life in Patients with Schizophrenia.  The Annals of Pharmacotherapy37P917-9182003
 
Kaneda Y: The impact of prolactin elevation with antipsychotic medications on subjective quality of life in patients with schizophrenia.  Clinical Neuropharmacology26182-1842003
 
Kaneda Y: Possible relationship between testosterone and co-morbid major depressive episode in male schizophrenia patients treated with typical antipsychotic medications.  Clinical Neuropharmacology26291-2932003

All Rights Reserved,Copyright(c)University of Tokushima.